Semaglutide
Long-acting GLP-1 receptor agonist research compound with 94% homology to native GLP-1.
From · per box of 10 vials
$45
First-in-class dual GIP/GLP-1 receptor agonist for metabolic research.
Tirzepatide is a dual GIP and GLP-1 receptor agonist that serves as a leading reference compound in obesity and glucose metabolism research. For laboratory research use only.
Dual receptor activation with biased agonism favoring cAMP production, increasing insulin sensitivity markers and reducing appetite signals.
SURMOUNT program results showed pronounced body weight reductions at higher doses; a standard comparator in incretin research.
Potent investigational compound for laboratory use only. Follow strict handling and reconstitution procedures.
From $55
per box of 10 vials
| Code | Dose | Price (USD) | Actions |
|---|---|---|---|
| TR5 | 5 mg | $55 | |
| TR10 | 10 mg | $70 | |
| TR15 | 15 mg | $100 | |
| TR20 | 20 mg | $120 | |
| TR30 | 30 mg | $145 | |
| TR40 | 40 mg | $180 | |
| TR50 | 50 mg | $240 | |
| TR60 | 60 mg | $265 | |
| TR100 | 100 mg | $360 |
Research Use Only: All products are strictly intended for laboratory research and scientific analysis only. Not for human consumption, clinical use, or diagnostic applications.
Long-acting GLP-1 receptor agonist research compound with 94% homology to native GLP-1.
From · per box of 10 vials
$45
Triple agonist (GLP-1, GIP, glucagon) research compound for metabolic studies.
From · per box of 10 vials
$100
Dual GLP-1/glucagon receptor agonist research compound.
From · per box of 10 vials
$355
Triple agonist (GLP-1, GIP, glucagon) research compound for metabolic studies — box of 10 vials.
From · per box of 10 vials
$180